Home » Topics » BioWorld Science

BioWorld Science
RSS

HitGen identifies new NTRK1 inhibitors

Nov. 6, 2019

Ark Biosciences reports topline proof-of-concept data for ziresovir in RSV

Nov. 6, 2019

TNBG-5602 induces lipid accumulation and antiproliferation in liver cancer cells through PPARgamma

Nov. 6, 2019

Incyte patent describes MAP4K1 inhibitors

Nov. 6, 2019

Tempest Therapeutics patents prostanoid EP2 and EP4 receptor antagonists

Nov. 6, 2019

Small molecules clear mutant Huntingtin protein

Nov. 6, 2019

First phase I data presented for influenza vaccine OVX-836

Nov. 6, 2019

Enzyme-replacement gene therapy encoding glucocerebrosidase attenuates PD phenotype

Nov. 6, 2019

EOLO-42016 shows promise in model of inherited ALS

Nov. 6, 2019

Investigators design mouse model of dwarfism with PCSK1 mutation

Nov. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...